Form 4 for CVKD Cadrenal Therapeutics, Inc.
Accepted 2023-03-22 00:00:00 ET · period of report 2023-03-21 · accession 0001213900-23-022065 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-22 | 2023-03-21 | CVKD | MURPHY JOHN RAYMOND | Dir | P - Purchase | $1.39 | +10.0K | 594.8K | +2% | +$13.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-21 | P | A | 10,000 | $1.39 | 594,792 | D | — | — | (F1) The amount of securities beneficially owned by Mr. Murphy following the reported transaction is correctly reported on this Form 4. The amount of securities beneficially owned by Mr. Murphy has been adjusted to correct immaterial errors in prior Form 4 filings that were filed with the Securities and Exchange Commission on January 24, 2023 and March 16, 2023. |